DocGo Q3 2024 revenue falls 26% to $138.7M; raises FY2024 cash flow guidance to $90-100M

DocGo Inc.

2024-Q3 EPS reported $0.22 revenue$495,722,059

Q3 revenue $138.7M (-26% YoY) from migrant program wind down; net income $4.5M (flat YoY).
Adjusted EBITDA $17.9M (+7% YoY); adjusted gross margin improved to 36.0% from 29.5%.
FY2024 revenue guidance tightened to $620-630M; adj. EBITDA guided to $70-75M; cash flow ops raised to $90-100M.
FY2025 revenue expected $410-450M with adj. EBITDA margin of 8%-10%.
Care gap closure patients >500k; expanded West Coast operations; Dr. Stephen Klasko appointed board chair.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.